When:
Thursday, October 3, 2019
All day
Where: 540 N Michigan Ave, Chicago, IL 60601
Cost: Cost varies. $275-$875
Contact:
Lurie Cancer Center
(312) 695-1300
Group: Robert H Lurie Comprehensive Cancer Center of Northwestern University
Category: Lectures & Meetings
Referred to as the most valuable breast cancer meeting worldwide for the practicing clinician, the Lynn Sage Breast Cancer Symposium provides 3.5 days of formal presentations and interactive case discussions. For over 20 years, this multidisciplinary CME program has been bringing together leading national and international medical, surgical, and radiation oncologists to present, debate, and evaluate cutting-edge technology and approaches in the management of breast cancer.
Progress across all aspects of patient care, including prevention, screening, detection, and survivorship, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, and novel biologic therapies are leading to new strategies and therapeutic options. The symposium focuses on the close cooperation required for effective multidisciplinary management of patients with breast cancer.
When:
Friday, October 4, 2019
All day
Where: 540 N Michigan Ave, Chicago, IL 60601
Cost: Cost varies. $275-$875
Contact:
Lurie Cancer Center
(312) 695-1300
Group: Robert H Lurie Comprehensive Cancer Center of Northwestern University
Category: Lectures & Meetings
Referred to as the most valuable breast cancer meeting worldwide for the practicing clinician, the Lynn Sage Breast Cancer Symposium provides 3.5 days of formal presentations and interactive case discussions. For over 20 years, this multidisciplinary CME program has been bringing together leading national and international medical, surgical, and radiation oncologists to present, debate, and evaluate cutting-edge technology and approaches in the management of breast cancer.
Progress across all aspects of patient care, including prevention, screening, detection, and survivorship, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, and novel biologic therapies are leading to new strategies and therapeutic options. The symposium focuses on the close cooperation required for effective multidisciplinary management of patients with breast cancer.
When:
Saturday, October 5, 2019
All day
Where: 540 N Michigan Ave, Chicago, IL 60601
Cost: Cost varies. $275-$875
Contact:
Lurie Cancer Center
(312) 695-1300
Group: Robert H Lurie Comprehensive Cancer Center of Northwestern University
Category: Lectures & Meetings
Referred to as the most valuable breast cancer meeting worldwide for the practicing clinician, the Lynn Sage Breast Cancer Symposium provides 3.5 days of formal presentations and interactive case discussions. For over 20 years, this multidisciplinary CME program has been bringing together leading national and international medical, surgical, and radiation oncologists to present, debate, and evaluate cutting-edge technology and approaches in the management of breast cancer.
Progress across all aspects of patient care, including prevention, screening, detection, and survivorship, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, and novel biologic therapies are leading to new strategies and therapeutic options. The symposium focuses on the close cooperation required for effective multidisciplinary management of patients with breast cancer.
When:
Sunday, October 6, 2019
All day
Where: 540 N Michigan Ave, Chicago, IL 60601
Cost: Cost varies. $275-$875
Contact:
Lurie Cancer Center
(312) 695-1300
Group: Robert H Lurie Comprehensive Cancer Center of Northwestern University
Category: Lectures & Meetings
Referred to as the most valuable breast cancer meeting worldwide for the practicing clinician, the Lynn Sage Breast Cancer Symposium provides 3.5 days of formal presentations and interactive case discussions. For over 20 years, this multidisciplinary CME program has been bringing together leading national and international medical, surgical, and radiation oncologists to present, debate, and evaluate cutting-edge technology and approaches in the management of breast cancer.
Progress across all aspects of patient care, including prevention, screening, detection, and survivorship, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, and novel biologic therapies are leading to new strategies and therapeutic options. The symposium focuses on the close cooperation required for effective multidisciplinary management of patients with breast cancer.